Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations

Thumbnail
View/Open
Rights
cbna
View Statistics
Show Statistical Information
Altmetrics
Share
Citation
World Health Organization. (‎2017)‎. Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations. World Health Organization. https://apps.who.int/iris/handle/10665/255887. License: CC BY-NC-SA 3.0 IGO
Description
40 p.
Document number
WHO/HIV/2017.23
Language
English
Collections
Metadata
Show full item record